GLP-2 "TIRZ" · 10MG
Tirzepatide-class dual agonist studied for GIP and GLP-1 receptor pathways.
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
Product Information
Research DatasheetProduct Overview
Tirzepatide is a synthetic 39-amino acid peptide engineered as a dual receptor agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In laboratory research it is used to investigate incretin biology, glucose homeostasis, insulin signaling, adipose metabolism, and dual receptor pharmacology. Manufactured under sterile conditions and third-party tested for identity and purity. For laboratory research use only. Not for human or veterinary use.
Molecular Profile
Research Applications
- ◆Dual incretin receptor pharmacology
- ◆Glucose and insulin signaling research
- ◆Adipose and hepatic metabolic pathway research
- ◆Energy homeostasis studies
- ◆Receptor binding and activation studies
- ◆Obesity and metabolic disease laboratory models
- ◆Peptide pharmacokinetics and stability research
- ◆Comparative incretin analog research
Quality Standards
For in-vitro research use only. Not for human consumption, diagnosis, or treatment.
Tirzepatide-class dual agonist studied for GIP and GLP-1 receptor pathways. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate. A downloadable Certificate of Analysis is available on request for every batch.
You may also like
GLP-3 "RET"
GLP-3 "RET" · 10MG
Next-gen tri-agonist studied for metabolic modulation.
